Nature's Sunshine Products (NATR) investor relations material

Market overview and growth trends

• Operates in the large and expanding global nutritional supplements market, valued at $1.1 trillion in 2024 and projected to grow at a 7.1% CAGR from 2025 to 2029.

• U.S. supplement market reached $69.3 billion in 2024.

• Health and wellness, along with entrepreneurial earning models, are key global mega-trends driving demand.

• Direct selling and gig economy models are significant contributors to industry growth.

Business model and product portfolio

• Multi-channel approach includes direct-to-consumer, specialty retail, health practitioners, and independent consultants.

• Two global brands with a diverse portfolio covering digestive, general health, cardiovascular, immune, sports/energy, and weight management needs.

• Manufactures 90% of products in-house, ensuring quality and compliance with FDA and international standards.

• Operates in over 40 countries, with sales distributed across multiple regions.

Financial performance and capital allocation

• Achieved 2025 sales of $480M and EBITDA of $49M, with a 2022-2025 CAGR of 4% for sales and 16% for EBITDA.

• Maintains a zero-debt balance sheet and has returned over $31M to shareholders through share repurchases between 2023-2025.

• Outperformed peers in revenue and EBITDA growth, and delivered a 210% total shareholder return since Jan 2023.

• FY 2026 guidance projects $500–$515M in net sales and $50–$54M in adjusted EBITDA.